Back to
MILLENNIUM MANAGEMENT LLC
BTAIQ4 quarters
Position history for
MILLENNIUM MANAGEMENT LLC's holdings in BioXcel Therapeutics, Inc.
Yes. Millennium Management holds 2,114,710 shares of BTAIQ (BioXcel Therapeutics), worth $3M, as of its Q2 2026 13F filing. It increased the position by 177,950 shares (+9.2%) from Q1 2026. Millennium Management has held BTAIQ since Q3 2025, across 4 quarterly 13F filings.
Current Value
$3M
Current Shares
2.1M
Total Value Change
+$349,925
Total Shares Change
+1.1M
Quarter-by-Quarter History
Other major holders of BTAIQ: OAKTREE CAPITAL MANAGEMENT LP, VANGUARD CAPITAL MANAGEMENT LLC, FMR LLC, VANGUARD GROUP INC